| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |